In the CDC’s most recent Morbidity and Mortality Weekly Report, the agency calls for greater research on antidepressant drug use during pregnancy. The CDC’s research in the past has indicated that there may be a link between the use of SSRI antidepressant medications during pregnancy and an increased risk of serious birth defects in children.
The CDC’s National Center on Birth Defects and Developmental Disabilities (NCBDDD) is working to improve the health of mothers and their children with their new Treating for Two initiative. Treating for Two aims to work with pregnant women to identify safer treatment options.